Table II.
Group | TG | TC | HDL-C | LDL-C |
---|---|---|---|---|
Young control (n=30) | 1.11±0.45a | 1.89±0.56a | 1.22±0.37a | 0.54±0.24a |
Aging control (n=27) | 4.32±2.20 | 3.55±0.73 | 1.68±0.42 | 1.61±0.46 |
AVT low dose (n=24) | 3.54±1.42 | 3.12±0.35b | 1.77±0.32 | 1.16±0.24a |
AVT high dose (n=26) | 3.06±0.85b | 2.81±0.40ac | 1.82±0.27 | 0.96±0.25ac |
P<0.01,
P<0.05, compared with the aging control group;
P<0.05, compared with the AVT low-dose group.
AVT, atorvastatin; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, high-density lipoprotein cholesterol.